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AbstrACt
Introduction Children with acute respiratory tract 
infections (ARTIs) are prescribed up to 11.4 million 
unnecessary antibiotic prescriptions annually. Inadequate 
parent–provider communication is a chief contributor, 
yet efforts to reduce overprescribing have only indirectly 
targeted communication or been impractical. This 
paper describes our multisite, parallel group, cluster 
randomised trial comparing two feasible interventions for 
enhancing parent–provider communication on the rate of 
inappropriate antibiotic prescribing (primary outcome) and 
revisits, adverse drug reactions and parent-rated quality of 
shared decision-making, parent–provider communication 
and visit satisfaction (secondary outcomes).
Methods/analysis We will attempt to recruit all eligible 
paediatricians and nurse practitioners (currently 47) at 
an academic children’s hospital and a private practice. 
Using a 1:1 randomisation, providers will be assigned to 
a higher intensity education and communication skills or 
lower intensity education-only intervention and trained 
accordingly. We will recruit 1600 eligible parent–child 
dyads. Parents of children ages 1–5 years who present 
with ARTI symptoms will be managed by providers trained 
in either the higher or lower intensity intervention. Before 
their consultation, all parents will complete a baseline 
survey and view a 90 s gain-framed antibiotic educational 
video. Parent–child dyads consulting with providers 
trained in the higher intensity intervention will, in addition, 
receive a gain-framed antibiotic educational brochure 
promoting cautious use of antibiotics and rate their 
interest in receiving an antibiotic which will be shared with 
their provider before the visit. All parents will complete a 
postconsultation survey and a 2-week follow-up phone 
survey. Due to the two-stage nested design (parents 
nested within providers and clinics), we will employ 
generalised linear mixed-effect regression models.
Ethics/dissemination Ethical approval was obtained 
from the Children’s Mercy Hospital Pediatric Institutional 
Review Board (#16060466). Results will be submitted for 
publication in peer-reviewed journals.
trial registration number NCT03037112; Pre-results.
IntroduCtIon
Antibiotic overuse and misuse contribute to 
the development of antibiotic-resistant infec-
tions that if left unchecked are estimated to 
cause 10 million deaths worldwide by 2050.1 
In the USA, antibiotic-resistant infections 
are responsible for at least 23 000 deaths and 
an additional 2 million infections annually.2 
Inappropriate antibiotic use also increases 
incidence of antibiotic-associated adverse 
drug reactions (eg, rash, diarrhoea, nausea 
and vomiting), which result in >140 000 
emergency department visits every year.3 
strengths and limitations of this study
 ► Implements a parent–provider communication in-
tervention based on a previously effective interven-
tion and adapted for feasibility in the US paediatric 
ambulatory setting.
 ► Works closely with a multicultural group of parents, 
providers and other stakeholders to ensure feasibil-
ity and appropriateness of intervention components, 
study procedures and study materials in Spanish 
and English.
 ► Adequately powered to detect differences between 
the higher and lower intensity interventions, with a 
1:1 randomisation of providers to intervention arms 
and a target sample of 1600 parents/child dyads.
 ► Data on primary outcomes (ie, rates of inappropri-
ate antibiotic prescribing), secondary outcomes (ie, 
revisits and adverse drug reactions, shared deci-
sion-making, quality of parent–provider communi-
cation and satisfaction) and potential covariates will 
yield novel insights into the effectiveness of each 
intervention.
 ► Provider training was limited to one 20 min session 
for all providers and one additional 50 min session 
for providers in the higher intensity arm.
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The majority of all antibiotic prescribing in the USA 
occurs in the outpatient setting where children receive 
49 million prescriptions annually.4 Children with acute 
respiratory tract infections (ARTIs) receive >70% of 
these prescriptions of which 29% are unnecessary (ie, 
either to treat a viral illness or an unnecessary broad-spec-
trum antibiotic).4 Despite some improvements, the most 
recent estimates suggest that antibiotics are prescribed 
for approximately 50% of ARTIs while it is estimated that 
only 27% of ARTIs are caused by bacterial infection.5 As 
a result, children are receiving up to 11.4 million unnec-
essary antibiotic prescriptions annually.5 Strikingly, an 
almost identical number was noted in a similar study 
conducted 16 years earlier (11.1 million unnecessary anti-
biotic prescriptions), suggesting there are considerable 
gains still to be made in reducing inappropriate use.6
Inappropriate antibiotic prescribing in the ambu-
latory setting has many causes, but the interaction 
between parents/legal guardians (hereafter referred to 
as parents) and providers is central. For their part, some 
parents still harbour misconceptions that make them 
think antibiotics are necessary when they are not.7 Never-
theless, parents generally desire antibiotics for their chil-
dren only when absolutely necessary8 and do not expect 
antibiotics for common colds.9 Instead, parents become 
dissatisfied when providers minimise children’s symp-
toms, fail to acknowledge parents’ appropriate concerns 
and/or do not offer a contingency plan if symptoms fail 
to resolve.10 11
Despite evidence to the contrary, providers perceive 
significant parental pressure for antibiotics and fear 
damaging the parent–provider relationship if they with-
hold prescriptions.12 13 Combined with the ever-increasing 
time constraints and focus on parent satisfaction ratings 
inherent in modern clinical practice, these beliefs greatly 
contribute to ineffective parent–provider communication 
about antibiotics. When providers perceive that a parent 
expects or hopes for an antibiotic, they are more likely to 
prescribe one.14 15 In a study of children with viral ARTIs 
where no prescription should have been given, providers 
gave a prescription to 52% of parents they believed 
were expecting an antibiotic compared with only 9% of 
parents who they believed were not expecting an anti-
biotic.16 Adding to this problem is providers’ mistaken 
belief that they can accurately predict parents’ desires. 
In fact, providers’ ability to accurately predict parents’ 
expectation for an antibiotic is significantly worse than 
chance at 24%–41% concordance.12 16 Even though 
parents rarely state a desire for antibiotics (1% of the 
time in clinical recordings), providers report frequent 
parent demands for antibiotics.17 Providers also mistak-
enly believe that meeting perceived parental expecta-
tions for antibiotics is necessary for parent satisfaction.13 
Parental satisfaction, however, is not related so much to 
whether or not they receive an antibiotic but more to the 
quality of communication with their provider.10 13 In fact, 
a recent observational study demonstrated that the use of 
what they termed ‘positive treatment recommendations’ 
(ie, comfort care) plus ‘negative treatment recommenda-
tions’ (ie, antibiotics will not help) was associated with the 
highest parent satisfaction.18
Current efforts to improve appropriate antibiotic use 
have only indirectly targeted parent–provider commu-
nication19 20 or have been found to be impractical.21 As 
described in several meta-analytic and systematic reviews, 
interventions have typically focused on education about 
antibiotics for providers or patients.19 20 While many have 
been successful in increasing knowledge about antibi-
otics and nationally antibiotic prescribing has evidenced 
modest reductions,8 22 more effective strategies that go 
beyond educational targets are needed to reduce overpre-
scribing rates to levels that will have a significant impact. 
A limited number of studies have been conducted that 
target parent–provider communication or shared deci-
sion-making, and they have already produced superior 
results.20 Of the communication interventions tested, only 
one has directly targeted provider perceptions of parental 
expectations alongside antibiotic education and shared 
decision-making.23 This study, which employed inten-
sive provider training and a multipage patient–provider 
interactive educational booklet, resulted in a significant 
decrease in antibiotic use. The intervention, however, was 
viewed as burdensome by providers and impractical for 
most real-world settings.21 Effective, practical interven-
tions are needed that address provider misconceptions 
about parent expectations, facilitate shared-decision 
making and improve aspects of communication that are 
most likely to increase parental satisfaction.
The goal of this study is to compare two feasible 
interventions for enhancing parent–provider commu-
nication to reduce the rate of inappropriate antibiotic 
prescribing. This study will compare the efficacy of a 
higher intensity provider education and communication 
skills intervention to a lower intensity provider education 
only intervention. We hypothesise that the parent–child 
dyads managed by providers trained in the higher inten-
sity intervention will demonstrate superiority to dyads 
managed by providers trained in the lower intensity inter-
vention on the primary outcome of rate of inappropriate 
antibiotic prescribing, as well as the secondary outcomes 
of revisits, adverse drug reactions and parent-rated quality 
of shared decision-making, parent–provider communica-
tion and satisfaction.
MEthods And AnAlysIs
Patient and public involvement
In the early planning stages for this study, we conducted 
focus groups and individual interviews with clinical, parent, 
payer and community stakeholders to assess the viability 
and inform the design of the study. We then recruited a 
Parent Research Associate who is a core member of our 
research team, attends all meetings, contributes to all 
decisions about the study and co-leads our Community 
Advisory Board (CAB). Our CAB comprises 15 parent, 
provider and community stakeholders and is diverse 
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(ie, three males, seven Latinx (three exclusively Spanish 
speaking) and three African-Americans). CAB meetings 
will occur every other month during year 1 and twice 
yearly in years 2 and 3. All aspect of the study design, 
settings, participant burden, materials, procedures, inter-
pretation of data and dissemination of study findings 
have and will be informed by the CAB and Community 
Research Associate. Study results will be disseminated to 
all clinic providers. A parent summary of findings will be 
developed and provided to study sites who will be encour-
aged to post in their facilities and/or mail to parents.
trial design, setting and participants
Trial design
A multisite parallel group, cluster randomised trial with 
balanced randomisation (1:1) will be performed in three 
ambulatory paediatric clinics in the USA. Recruitment 
of providers will start in January of 2017 and continue 
throughout the study as new providers are hired. Providers 
(physicians and nurse practitioners) will be randomly 
assigned to training in either the higher intensity or lower 
intensity intervention described below. Once providers 
have been randomised and trained, eligible parent–child 
dyads will be enrolled and exposed to management by 
a provider who was trained in one of the interventions. 
Recruitment of parent–child dyads will start in March of 
2017 and continue through December of 2018. Parents in 
both arms will receive education on the pros and cons of 
antibiotics for common infections and tips for communi-
cating with their provider. Blinding of providers will not 
be feasible in this study; however, parents will be blinded 
as they will not be told what study arm their provider is 
in, nor informed about differences between the study 
interventions. Study team members who conduct chart 
review to code appropriateness of antibiotic prescriptions 
and code session audiotapes for intervention fidelity will 
be blinded. A principal investigator (KG) will monitor 
recruitment, retention (bimonthly) and adverse events 
(quarterly; blinded to study arm) in this low-risk study. 
Adverse events will be collected from parents at 2-week 
follow-up, through chart review and spontaneously from 
clinic staff. Any protocol modifications will be submitted 
for Institutional Review Board review and communicated 
to all relevant parties before implementation.
Randomisation
To protect against practice effects (tendency for 
providers to have more consistent beliefs and behaviours 
within their practice compared with providers in other 
practices), we will randomise providers rather than 
clinic sites. We did this because the intervention compo-
nents are not easily transferred between providers 
making the risk of contamination a much smaller 
threat to validity than practice effects. As detailed below 
in the higher intensity provider training section, we 
will employ several strategies to reduce the chance of 
contamination across study arms. We will use clinic data 
on visits among our target population from the past 
six months to assign each provider to a large or small 
patient volume group. The study statistician will then 
stratify the randomisation of providers to ensure each 
study arm is balanced across large and small volume 
providers and across clinics. The study statistician will 
place the intervention group assignment in sealed enve-
lopes labelled with providers’ names. Providers will be 
given their envelopes at the conclusion of a brief study 
orientation and informed consent meeting and before 
completing the baseline assessment.
Setting
Study sites will be an academic medical centre (Chil-
dren’s Mercy Hospital Primary Care Clinic (CMH 
PCC)) and both locations of a private practice (Heart-
land Primary Care (HPC)). CMH PCC sees a racially 
and ethnically diverse group of patients (41% Afri-
can-American/black, 29% Hispanic, 18% white) from 
the Kansas City metropolitan area, of which 73% are 
covered by Medicaid. CMH PCC has 38 providers (28 
paediatricians and 10 nurse practitioners) and treats 
approximately 2100 children with an ARTI that meet 
study inclusion criteria yearly. HPC is a communi-
ty-based private practice with two locations in sub-urban 
Kansas City serving a diverse patient population (14% 
African-American/black, 16% Hispanic, 75% white; 
42% covered by Medicaid). HPC has nine paediatric 
providers (six paediatricians and three nurse practi-
tioners) who care for 2000 children that meet study 
inclusion criteria annually. Approximately 20% of 
parents at study sites are Spanish speaking.
Participants
This study involves providers and parent–child dyads. We 
will attempt to recruit all eligible providers at all study 
sites (paediatricians, paediatric nurse practitioners; 
n=47), defined as those who regularly treat patients that 
meet our inclusion criteria. Providers primarily assigned 
to administration, urgent care or specialty clinics that 
serve complex care patients will not be eligible. We will 
conduct brief study orientation and informed consent 
meetings to enrol providers during regularly scheduled 
clinic meetings or individual contacts.
We will recruit up to 1600 parent–child dyads (see 
figure 1). Dyads will be eligible if the patient is between 
ages 1 and 5 years (ie, before sixth birthday), presents 
with ARTI symptoms (eg, cough, congestion, difficulty 
breathing, sore throat, ear ache) and his/her parent 
is fluent in English or Spanish. Children will not be 
eligible if they have received an antibiotic in the last 
30 days, have a concurrent probable bacterial infec-
tion (eg, urinary tract infection, soft tissue infections), 
known immunocompromising conditions (eg, HIV, 
malignancy, solid-organ transplant, chronic corticoste-
roid use) or factors that make shared decision-making 
around prescribing an antibiotic extremely complex, 
like children with complex chronic care conditions (eg, 
cystic fibrosis),24 or who require hospitalisation during 
 o
n




pen: first published as 10.1136/bmjopen-2017-020981 on 9 May 2018. Downloaded from 
4 Goggin K, et al. BMJ Open 2018;8:e020981. doi:10.1136/bmjopen-2017-020981
Open Access 
the visit. We will include patients with penicillin allergy 
as shared decision-making with this group is espe-
cially important given more limited treatment options. 
Parents or children who have previously participated 
in the study will not be eligible to participate again. 
Potentially eligible dyads will be identified through 
prescreening all appointments and parents will be given 
a study flyer on check-in. Potential eligible dyads will be 
greeted in the exam room before the provider arrives, 
given a short synopsis of the study and offered eligi-
bility screening. If more than one caregiver is with the 
child, they will be asked to designate one person who 
will complete the informed consent and all assessments. 
Providers will have no role in identifying potentially 
eligible dyads, screening, consenting or data collection.
trial interventions
Higher intensity intervention
With attention to the feasibility in the US healthcare 
system, this intervention will be informed by a series of 
evidence-based interventions conducted in the UK and 
Europe: Enhancing the Quality of Information-sharing in 
Primary care (EQUIP),23 25 Improving the Management 
of Patients with Acute Cough Trial (IMPACT),26 27Stem-
ming the Tide of Antibiotic Resistance (STAR)28 29 and 
Genomics to combat Resistance against Antibiotics in 
Community-acquired LRTI in Europe (GRACE).30
Figure 1 Schematic diagram of parent–patient dyad participant flow.
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Higher intensity arm provider training
Providers in this arm will receive two trainings. First, a 
20 min, in-person general education training provided by 
a study physician (ALM, JGN) will cover the pros and cons 
of antibiotics, the impact of inappropriate use, Centers 
for Disease Control and Prevention antibiotic prescribing 
guidelines, common reasons for antibiotic misuse and 
viewing/discussing of the parent educational cartoon 
(described below). Didactic and interactive learning strat-
egies will be employed to review the appropriate diagnostic 
criteria to help distinguish a viral ARTI from a bacterial 
ARTI, as well as the recommended narrow spectrum anti-
biotic for bacterial ARTI. Second, providers will receive a 
50 min, in-person training on parent-centred communi-
cation skills provided by a behavioural psychologist (KG). 
The training will use a variety of educational strategies 
including viewing/discussing of motivational and role 
model videos, lecture and group discussion. The goal is 
to enhance providers’ confidence in use of parent-cen-
tred communication strategies (eg, open-ended ques-
tions, affirming and elicit–provide–elicit) and the study 
trifold brochure to conduct key aspects of the EQUIP/
IMPACT/STAR/GRACE interventions during consul-
tations. Specifically, they will learn to (1) elicit parents’ 
expectations, (2) affirm parents’ concerns, (3) provide 
an evidence-based estimate of likely illness duration, (4) 
provide gain-framed antibiotic information, (5) recom-
mend options for symptom relief, (6) identify triggers for 
reconsult and contingency plans and (7) elicit parents’ 
thoughts on the plan. Providers will also learn to use the 
study trifold brochure to ensure that they complete all 
necessary aspects of the intervention and provide written 
notes for parents to refer to after the visit. The inside of 
the study trifold brochure provides gain-framed informa-
tion about when antibiotics are and are not necessary and 
what risks are involved in taking antibiotics. Research has 
shown that people react to the same trade-off in different 
ways depending on whether the possible outcomes are 
presented as losses or gains.31 In this study, we will train 
providers and tailor our parent materials to highlight the 
gains of not using antibiotics (eg, staying safe from side 
effects, making sure that effective cures are available in 
the future, knowing that their child’s body will fight off 
most ARTI on its own) that may increase parents’ comfort 
with not getting an antibiotic prescription for their child. 
Drawing from the EQUIP study,25 the outside of the 
brochure includes a place to write the child’s first name; 
check boxes to indicate the diagnosis, recommended 
home care treatments and reasons for reconsultation; 
expected recovery time, if antibiotics are needed, and tips 
for communicating with providers.
To reduce their reliance on guessing what parents want, 
providers will also be trained to rely on parents’ antibi-
otic desire ratings taken from their baseline survey and 
provided at the start of each visit via a sticky note on the 
exam room door where parent–child dyads will be waiting. 
To assess fidelity to the communication skills, we will 
audio record a subsample of visits (10%) in both higher 
and lower intensity arms and objectively code use of key 
communication strategies using established methods that 
we have successfully employed in other studies.32 33 We 
will deliver in-person provider training as studies have 
shown the value of an active approach over more passive 
web-based versions,34 but we will also develop web-based 
refresher trainings.
Higher intensity arm parent training
In exam rooms prior to the consultation, parents will 
complete the baseline survey, view a 90 s educational 
cartoon video with accompanying educational trifold 
brochure and rate their desire for antibiotics via a tablet 
computer. The educational video uses gain-framed 
messages31 35 to explain when antibiotics are and are not 
indicated while emphasising the risk of side effects and 
the creation of resistant organisms. It also highlights what 
information should be provided during the consultation 
(eg, an estimate of illness duration, recommendations for 
system relief and triggers for reconsult and contingency 
plans). Parents in this arm will receive a hard copy of the 
study trifold brochure.
Lower intensity intervention
This intervention will be modelled on proven parent-fo-
cused and provider-focused educational interventions 
used in previous studies.19 34 36–44 Providers will complete 
the same 20 min, in-person general education training 
described above. Parents will receive the same parent 
training described above except that parents will not 
receive a hard copy of the study trifold brochure and their 
antibiotic desire ratings will not be shared with providers.
Several measures will be taken to reduce the likeli-
hood of contamination between arms. Specifically, we will 
(1) train study team members to ensure that all of our 
communications (written or in person) with providers in 
the lower intensity arm do not reveal any of the strategies 
from the higher intensity training, (2) review the impor-
tance of keeping intervention arms distinct in randomised 
controlled trial designs during training, (3) directly ask 
providers to pledge not to share any details of the addi-
tional communication skills training with their colleagues 
randomised to the lower intensity arm, (4) control the 
dissemination of the trifold brochure to ensure that only 
parents who are consulted by providers in the higher 
intensity arm receive them and (5) offer communication 




At baseline, providers will complete a brief survey 
collecting demographic data and providers’ views on 
parent interest in antibiotics for viral illness, their 
comfort with telling parents that antibiotics are not 
necessary and their concern about parents’ responses. 
Once parent–child dyad recruitment is complete, a brief 
survey mirroring the baseline provider assessment and a 
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brief (<10 min) semistructured individual interview will 
be conducted with providers and administrators to learn 
about their experience of being in the study, suggestions 
for improvement and ideas about disseminating to other 
settings. Providers/administrators will not receive incen-
tives for study participation.
Parents
At baseline, immediately before their scheduled visit with a 
provider, parents will complete a brief tablet computer-ad-
ministered Research Electronic Data Capture (REDCap) 
survey about their antibiotic knowledge and interest in 
antibiotics for their child’s current condition. They will 
then view the educational video and indicate their interest 
in antibiotics for their child’s current condition again and 
rate the likelihood of actually receiving antibiotics during 
their visit. After meeting with their provider, parents will 
complete a brief survey about their experience of the visit 
including their rating of shared decision-making, satis-
faction with parent–provider communication and overall 
satisfaction with the visit. Two weeks later, parents will be 
contacted via phone to complete a follow-up survey to 
assess resolution of child’s illness, any additional health-
care visits and/or treatment, if contingency or ‘back-up’ 
prescriptions were filled, presence and severity of side 
effects from any antibiotics administered, use of home 
care treatment suggested by provider, assessment of the 
educational video and brochure, and satisfaction with 
study participation. Electronic medical record (EMR) 
data will be abstracted using a standardised data collec-
tion form and evaluated by study physicians to determine 
the appropriateness of antibiotic prescribing. Parents will 
be provided with $10 per completed survey in recogni-
tion of their time and effort.
Measures
Interest in assessing patient/parent–provider communi-
cation has garnered significant attention, but measure-
ment challenges remain. Despite a large number of 
published instruments, availability of valid, reliable and 
scalable measures is a recognised barrier to progress in 
research and implementation of patient-centred care.45 
Lack of patient involvement in scale development has 
been cited as a contributing factor, so we have engaged 
parent and provider stakeholders in the selection of 
measures for this study. All measures have been adapted 
based on their feedback, pilot testing including cognitive 
debriefing was performed to ensure the briefest possible 
assessment of study outcomes. All measures were trans-




Our primary research question is which of the two inter-
ventions leads to a lower rate of inappropriate antibi-
otic prescribing. We hypothesise that the rate among 
providers in the higher intensity arm will be lower than 
the rate produced by providers in the lower intensity 
arm. If the rates do not significantly differ, we will recom-
mend the lower intensity intervention as preferable for 
dissemination as its implementation requires less time 
and resources. Inappropriate prescribing will be assessed 
on a weekly basis by study physicians, blinded to study 
arm, who will review the medical record documentation 
for each enrolled patient’s visit to determine if inap-
propriate antibiotic prescribing occurred. Prescriptions 
will be considered inappropriate if they meet any of the 
following criteria: (1) antibiotic prescribed for a viral 
ARTI, (2) antibiotic prescribed for a presumed bacterial 
ARTI that does not meet table 1 criteria, (3) broad-spec-
trum antibiotic prescribed for a bacterial ARTI in a child 
without a penicillin allergy or (4) non-recommended 
alternative antibiotic prescribed for a bacterial ARTI (see 
table 2) in a child with a penicillin allergy.
Instead of relying on diagnostic codes as has been done 
in previous studies,46 47 the study physicians will assess the 
appropriateness of the patient’s diagnosis by reviewing 
detailed symptoms, physical examination findings and 
Table 1 Diagnostic criteria for acute respiratory tract infections (ARTIs)19 34 36 46 51
Bacterial ARTI Diagnostic criteria
Acute otitis media
(either criteria)
1. Fever≥38.3°C (101°F) with either a or b:
a. Moderate to severe bulging of tympanic membrane on exam
b. Mild bulging of tympanic membrane and recent (<48 hours) onset of ear pain
3. New onset of otorrhoea not due to acute otitis externa
Sinusitis
(any of the three criteria)
1. Daytime cough or nasal discharge for >10 days
2. High fever (>39°C) with purulent nasal discharge or facial pain lasting three consecutive days at 
the beginning of the illness
3. Worsening signs or symptoms characterised by the new onset of fever, headache or increase in 




1. Fever, tachypnoea and focal findings on pulmonary exam




1. Fever, pharyngitis and positive rapid streptococcal antigen test or culture
2. Lack of viral signs and symptoms
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diagnostic tests in the EMR. This will guard against the 
potential bias of relying on diagnostic codes alone as 
clinicians sometimes match diagnostic codes to support 
their antibiotic prescribing.12 Children determined to 
have a bacterial infection will need documentation of 
the specific diagnoses and the clinical criteria confirming 
that diagnosis (listed in table 1). Ten per cent of all 
chart reviews will be verified by the other study physician 
blinded to the initial coding and study group. Overall 
antibiotic prescription rate for different ARTI diagnoses 
by arm will also be reported.
secondary outcomes
Revisits and adverse drug reactions
We will determine if children seen by providers in 
the two study arms differ in terms of revisits and/or 
adverse drug reactions. Data on these clinical outcomes 
will be collected via follow-up phone calls with parents 
conducted 2 weeks after the visit. Parents will be asked 
if any additional healthcare visits and/or treatment 
occurred and, if antibiotics were given to the child, if any 
side effects or adverse drug reactions occurred. Parents 
will also be asked to report on when their child’s symp-
toms improved, if contingency prescriptions were filled, 
use of home care treatment suggested by the provider, 
assessment of the educational video and brochure, and 
satisfaction with study participation.
Shared decision-making
We will assess parent ratings of shared decision-making 
using an adapted version of the three-item CollaboRATE 
questionnaire.48 This very brief (<30 s) scale was devel-
oped with input of end users and assesses the ‘effort’ that 
providers put forward to initiate shared decision-making. 
Members of our community advisory board and partic-
ipants in several studies have strongly preferred the 
CollaboRATE scale to other measures of shared deci-
sion-making, especially for more routine healthcare 
issues.49 Items are: ‘How much effort was made to … 
(1) help you understand your child’s health issue?; (2) 
listen to the things that matter most to you about your 
child’s health issues?; and (3) include what matters most 
to you in choosing what to do next?’ Items are scored 
on a 10-point response scale ranging from 0 ‘no effort 
was made’ to 9 ‘every effort was made.’ In a simulation 
study, the CollaboRATE scale demonstrated discrimina-
tive validity between six standardised patient–provider 
encounters that included varied amounts of shared deci-
sion-making, concurrent validity with other measures of 
shared decision makingDM, excellent test–retest reli-
ability and sensitivity to change.50
Quality of parent–provider communication
We will use a single item: ‘How satisfied were you with 
the communication between you and your child’s 
healthcare provider?’ with a five-point Likert-type 
response format ranging from ‘very dissatisfied’ to ‘very 
satisfied’.
Overall satisfaction with the visit
We will use a single item: ‘Overall, how satisfied were 
you with the visit?’ with a five-point Likert-type response 
format ranging from ‘very dissatisfied’ to ‘very satisfied’.
data analyses
Power and sample size
Prior research examining our primary outcome has 
shown that 30% of the antibiotics prescribed in the outpa-
tient ARTI visits are inappropriate.5 Prior behavioural 
intervention studies have produced 20%–81% reductions 
in inappropriate prescribing,46 51 with statistically signifi-
cant differences between intervention and control arms 
(effect sizes: 8.3%46 and 13.1%).51 Based on the intraclass 
correlation coefficient (ICC) observed in the Meeker et 
al study which is most similar to our study, we assume an 
ICC of .04. Assuming 30% inappropriate prescribing at 
baseline and a 20% decrease in the lower intensity arm 
and a conservative 50% decrease in the higher intensity 
arm following intervention, with 40 providers (clusters), 
α of .05 and 80% power, we will need a sample size of 
760 per arm to detect a 9% difference between arms 
(inappropriate antibiotic 24% in the lower intensity arm 
vs 15% in the higher intensity arm after intervention). 
Consistent with our historical retention rates in similar 
studies in the same setting, we will protect against an attri-
tion rate of 5% and aim to recruit 1600 participants to 
ensure adequate power to assess our primary outcome 
and secondary outcomes.
Planned analytic strategy
All analyses will be conducted using an intent-to-treat 
strategy with available data. Initial analyses will examine 
the underlying distributions of the primary and secondary 
outcomes. ‘Ceiling effects’ on these measures of parent 
Table 2 Appropriate antibiotic selection19 36 46 51
Bacterial acute respiratory tract 
infection Primary antibiotic Secondary antibiotics for penicillin allergy
Acute otitis media Amoxicillin Cefdinir, cefpodoxime, ceftriaxone, cefuroxime, clindamycin
Community-acquired Pneumonia Amoxicillin Cefpodoxime, cefprozil, cefuroxime, clindamycin
Sinusitis Amoxicillin Cefdinir, cefpodoxime, cefuroxime, clindamycin
Streptococcal pharyngitis Amoxicillin Cephalexin (preferred unless previous type I hypersensitivity 
reaction to penicillin) clindamycin, azithromycin
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satisfaction are not uncommon and depending on the 
level of skewness, we may elect to dichotomise specific 
scales. We will construct an analytic model to assess the 
impact of intervention type on our primary outcome of 
inappropriate antibiotic prescribing. This is a two-stage 
nested design, with parents nested within providers 
(level 1 units) and study site (level 2 units). Consequently, 
ordinary least squares and logistic regression models are 
not appropriate since the data violate the independently 
and identically distributed assumption. We will use 
generalised linear mixed-effect regression models using 
Stata52 which allow for easy specification of both fixed 
and random effects, including accommodating ≥1 cluster 
variables. Alternative covariance structures will be inves-
tigated; though we hypothesise the exchangeable (or 
compound symmetry) structure will suffice. We will 
employ robust SEs to help minimise misspecification and 
examine time as a potential random effect. The data will 
be analysed using a post-test-only approach. Next, we 
will examine the effects of the potential covariates (eg, 
parent’s/patient’s gender, insurance type, parent’s self-re-
ported race and ethnicity, parent’s educational attain-
ment and provider’s years of clinical experience) on the 
primary and secondary outcomes. Our goal is to identify 
parsimonious final models with the fewest covariates that 
best describe the outcomes.
Additionally, we will explore the heterogeneity of treat-
ment effect or the possibility that one or both of the 
interventions work better for specific groups. Variables 
for consideration include language spoken at home, 
language the visit was conducted in and age of child. We 
will create a binary indicator for each variable and include 
each as an interaction term in the regression models. We 
will examine these interaction terms across intervention 
arms and explore within-arm differential trends in our 
primary and secondary outcomes over time.
Missing data
All analyses will be conducted with available data. We 
do not anticipate important amounts of missing data as 
all data for primary outcomes are collected in a single 
visit before incentives are offered and we will require 
responses in the REDCap form.
EthICs And dIssEMInAtIon
Ethical approval was obtained from the Children’s 
Mercy Hospital Pediatric Institutional Review Board 
(#16060466). All participants will provide written 
informed consent prior to participating in the study. We 
will employ multiple strategies to protect confidentiality 
of personal information about potential and enrolled 
participants. Prescreening of patients will be conducted 
exclusively by trained study staff on password-protected 
computers and REDCap data collection tool. Appoint-
ments with potential participants will be flagged in elec-
tronic clinic scheduling systems accessible only to clinic 
and study staff. Enrolled parent and patient participants 
will complete all measures in REDCap projects, which will 
only be accessible to study staff who must use multiple 
passwords to access REDCap through the Children’s 
Mercy network. Personal identifying information, namely 
medical record number and contact information, is 
marked as an identifier in REDCap and is then censored 
when the database is downloaded for analysis. All iden-
tifying information will be removed with the deletion of 
the REDCap project at the end of the study. Audio files 
of clinic visits will be stored in a password-protected file 
on the Children’s Mercy server that is only accessible to 
members of the study staff. Consent forms and signature 
logs for reimbursements will be secured in a locked file 
cabinet within a locked office on a secured floor.
A full data package will be maintained by the investi-
gators at Children’s Mercy Hospital for at least 7 years 
after data collection is complete. Third-party access to the 
full data package will be addressed by Children’s Mercy 
Hospital on a case-by-case basis.
Results will be disseminated through publication in 
peer-reviewed journals and conference presentations. 
Study progress and findings will also be updated on  clini-
caltrials. gov (#NCT03037112).
dIsCussIon
Effective parent–provider communication facilitates 
rapport-building, exchange of critical information and 
shared decision-making which ultimately has the potential 
to reduce inappropriate antibiotic prescribing and use. 
Nevertheless, efficacious and feasible training interven-
tions that enhance effective parent–provider communica-
tion, shared decision-making and antibiotic prescribing 
are lacking. This study will be the first to compare the 
efficacy of two interventions directly targeting parent–
provider communication about antibiotics in the US 
outpatient paediatric setting. It will also provide novel 
insights about parental expectations for antibiotics 
following the receipt of gain-framed information and 
providers’ experience of the interventions. If successful, 
the superior intervention could be widely disseminated 
and potentially lead to reduced healthcare costs through 
more appropriate antibiotic use, decreased additional 
visits by parents who may not have felt satisfied with their 
initial visit and ultimately less antibiotic resistance.
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